Friday, June 07, 2019 8:02:15 AM
Some are purely financial for those who target, short and NSS a company. I will remind you to look up the story of Overstock.com.
The folks wanting to keep a company down will target a company and short it causing the stock price to plummet, and then cover their short far lower, or never if the company goes under. Negative chatter on the message boards or spurious articles is a common practice. Remember, it is far easier to scare folks into selling than it is to spur them into buying. Look at the trading here. Asks slaps rarely move the needle, but a series of 10,000 sells drops the bid like a rock. It’s all just for the money. Easy picking if you are big offshore hedge fund that can afford the fees.
The other big reason is to actually do harm to the company and attempt to run them out of business. That happens a few ways. One is damaging the PPS so the company looks bad and harms their appearance. For example, if CELZ continued it run last summer and was trading at .20, it will look like a good startup company getting on its feet. Even though not one business fact about CELZ has changed, what does it look like to the outside world now? It looks like a stinky pinky about to lose its QB status. How does that look? Mission accomplished.
The other way, and Overstock.com went through this, is when the PPS falls and the market share decreases, the company loses its ability to get traditional loans from the baking industry. They look too high risk, don’t meet certain standards, etc. This forces the company to dilute stock for cash, compounding the problem. For example, if CELZ needed $300,000 and we were trading at .03 and they needed to issue a note, how many shares would they have to dilute vs. needing $300,000 at trading at .003? The goal is to force the company into another ugly note and look bad and damage the company.
I ask this question all the time. Who would be against a company that is starting up offering a great new NON MED, NON SURGICAL fix to a common problem?
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM